Previous 10 | Next 10 |
First quarter revenue grew 9% to $64.5 million Consumer revenue grew 17% year over year due to the addition of telehealth revenue On track to achieve FY2023 financial guidance SOUTH SAN FRANCISCO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME)...
Shares of genetic data healthcare company 23andMe (NASDAQ: ME) jumped higher on Monday morning, as did many other beaten-down stocks. By noon ET, 23andMe stock was up 16% and trading volume was nearly double its average, even though there were still four hours left in the trading da...
Gainers: CinCor Pharma CINC +66% . Karuna Therapeutics KRTX +61% . 23andMe ( ME ) +22% . Cerevel Therapeutics ( CERE ) +20% . Quoin Pharmaceuticals ( QNRX ) +16% . Losers: Reata Pharmaceuticals RETA -31% . uniQure QUR...
Major earnings expected after the bell on Monday include: 3D Systems ( DDD ) Lemonade ( LMND ) Novavax ( NVAX ) Take-Two Interactive Software ( TTWO ) Upstart Holdings ( UPST ) For further details see: Notable earnings after Monday's close...
23andMe ( NASDAQ: ME ) is scheduled to announce Q1 earnings results on Monday, August 8th, after market close. The consensus EPS Estimate is -$0.16 (+36.0% Y/Y) and the consensus Revenue Estimate is $61.6M (+4.0% Y/Y). Over the last 3 months, EPS estimates have seen 1 ...
SOUTH SAN FRANCISCO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will report financial results for the fiscal year 2023 (FY2023) first quarter after the market...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Reddit stocks have been so successful (or at least intriguing) that Reddit has quickly become an investing hub. The site has a huge community of investors and traders who use it as a platform for their investments. The tr...
Two new Breakout Stocks for Week 26 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now up to +88.1% YTD. High frequency breakouts continue despite Negative Momentum Gauge® signals with peak gains in 2 of 4 picks above 10%: ABUS +13....
23andMe is a consumer-facing genetics testing company, one of the largest in terms of genetic databases. However, there are some glaring financial risks to consider if you want to invest in the company: slow test kit growth and profitability. New attempts to move towards drug deve...
3 Best Penny Stocks to Add to Your Watchlist Right Now With another day of buying and selling penny stocks, there is a lot that investors need to understand. For one, we are once again seeing some bearish sentiment across the board. While it is not nearly as great as the previous tr...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial resu...
SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading genetic health and biopharmaceutical company, in collaboration with 20 lung cancer advocacy organizations, today announced a new study to help advance research in lung cancer. The focus of the Lun...